ARCHIVES

Scope Of Panel’s Inquiry Outlined In Letter To Members

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

NCAB ‘Incredulous’ Over Proposed Ethics Rules, Bard Members Threaten Resignation In Letter

October 4, 1991

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

ASCO, NCCS Call For Oncology Center

September 13, 2002

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011